Boehringer Ingelheim Hernexeos approved in China for previously treated patients with HER2-mutant advanced NSCLC Ruchika Sharma2 Sept 2025 10:50 AM ISTBoehringer Ingelheim has received approval for HERNEXEOS (zongertinib tablets) from China's National Medical Products Administration (NMPA) as...
Toripalimab-Based Cisplatin-Free Strategy Efficacious, safe in Advanced NPC: JAMA Dr Riya Dave1 Sept 2025 9:00 PM ISTResearchers have found in a phase 3 trial that toripalimab combination therapy without cisplatin proved feasible, offering high failure-free survival...
Study Finds No Clear Link Between Vitiligo and Cancer Risk Dr Riya Dave31 Aug 2025 11:00 PM ISTResearchers have discovered that patients with vitiligo, a chronic autoimmune skin disorder that occurs in 1-2% of the world's population, do not seem...
From Scan to Strategy: Study evaluates Impact of 3D CT and Virtual Endoscopy on Airway Management in Head and Neck Cancer Dr Monish Raut31 Aug 2025 9:30 PM ISTRecent study evaluates the impact of advanced airway assessment techniques-specifically 3D computed tomography (3D CT) reconstruction and virtual...
Cachexia index as a Biomarker for Cancer Cachexia and Quality of Life in Gastric Cancer: Study Dr Riya Dave29 Aug 2025 11:00 PM ISTResearchers have found in a new study that cachexia index (CXI) may be a valuable indicator for assessing cancer cachexia and health-related quality...
Pembrolizumab Significantly Improves Event-Free Survival in Head and Neck Cancer: NEJM Dr Riya Dave29 Aug 2025 10:15 PM ISTAccording to a recent study adding perioperative pembrolizumab to standard therapy such as surgery and radiotherapy with or without cisplatin...
AstraZeneca Imfinzi application granted priority review by USFDA for resectable early stage gastric, gastroesophageal junction cancers Ruchika Sharma29 Aug 2025 10:30 AM ISTCambridge: AstraZeneca has announced that its supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab) has been accepted...
Chinese Medical Journal study highlights the role of artificial intelligence in prostate cancer management Dr. Kamal Kant Kohli28 Aug 2025 8:00 PM ISTCancer is a significant global health issue affecting millions worldwide. Among the different types of cancer, prostate cancer (PCa)-which affects the...
Cancer Burden Analysis Across 43 Cancer Registries in India: 5 Key Highlights Dr Jeegar Dattani28 Aug 2025 7:00 AM ISTA large cross-sectional study has revealed significant regional disparities in cancer incidence across India and an overall rising cancer burden. The...
Risk of a second cancer after early breast cancer is low, reports research Dr. Kamal Kant Kohli28 Aug 2025 5:00 AM ISTFor women diagnosed with early breast cancer, the long-term risk of developing a second primary cancer is low (around 2-3% greater than women in the...
Type 2 diabetes blood factors drive breast cancer aggression, finds BU study Dr. Kamal Kant Kohli27 Aug 2025 9:00 PM ISTPeople with type 2 obesity-driven diabetes tend to have more aggressive breast cancers, but no one knows exactly why. A new study by researchers at...
Endoscopy Every Three Years Cuts Gastric Cancer Death Risk: Cohort Study Medha Baranwal27 Aug 2025 8:30 PM ISTSouth Korea: The question of how often screening endoscopy should be performed to effectively reduce gastric cancer (GC) deaths has remained...
